THER-14. INFLUENCE OF CLINICAL PARAMETERS ON THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER BRAIN METASTASES (NSCLCBM)

INTRODUCTION: Non-small cell lung cancer brain metastases (NSCLCBM) patients have a dismal prognosis. Immune checkpoint inhibitors (ICI) have resulted in improved outcomes in a subset of patients, although limited information exists on the impact of ICI in patients with NSCLCBM. METHODS: We reviewed...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauko, Adam, Thapa, Bicky, Muhsen, Baha’eddin, Borghei-Razavi, Hamid, Wei, Wei, Chao, Samuel, Stevens, Glen, Peereboom, David, Yu, Jennifer, Murphy, Erin, Angelov, Lilyana, Mohammadi, Alireza, Suh, John, Barnett, Gene, Pennell, Nathan, Ahluwalia, Manmeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213173/
http://dx.doi.org/10.1093/noajnl/vdz014.057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213173/
http://dx.doi.org/10.1093/noajnl/vdz014.057

Ejemplares similares